Pamela Egan

2.8k total citations
32 papers, 284 citations indexed

About

Pamela Egan is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Pamela Egan has authored 32 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Public Health, Environmental and Occupational Health and 10 papers in Genetics. Recurrent topics in Pamela Egan's work include Palliative Care and End-of-Life Issues (9 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Cancer survivorship and care (6 papers). Pamela Egan is often cited by papers focused on Palliative Care and End-of-Life Issues (9 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Cancer survivorship and care (6 papers). Pamela Egan collaborates with scholars based in United States, Italy and United Kingdom. Pamela Egan's co-authors include Adam J. Olszewski, Thomas W. LeBlanc, John L. Reagan, Rabin Niroula, Emmanuelle Bélanger, Patrycja M. Dubielecka, Ari Pelcovits, James R. Klinger, Joel S. Greenberger and Lawrence D. Recht and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cardiovascular Research.

In The Last Decade

Pamela Egan

29 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela Egan United States 9 120 99 98 63 54 32 284
Rocío Cárdenas‐Cardós Mexico 11 135 1.1× 88 0.9× 131 1.3× 41 0.7× 36 0.7× 41 344
Stacy Epstein United States 6 81 0.7× 108 1.1× 185 1.9× 37 0.6× 75 1.4× 10 444
С. Р. Варфоломеева Russia 8 66 0.6× 50 0.5× 57 0.6× 27 0.4× 23 0.4× 118 226
Giacomo Loseto Italy 11 52 0.4× 158 1.6× 38 0.4× 37 0.6× 33 0.6× 24 343
Marion Strullu France 11 88 0.7× 61 0.6× 68 0.7× 17 0.3× 34 0.6× 29 277
Deepam Pushpam India 10 64 0.5× 91 0.9× 52 0.5× 25 0.4× 81 1.5× 74 272
Anita J. Kumar United States 11 74 0.6× 95 1.0× 47 0.5× 20 0.3× 29 0.5× 37 245
Holger Hauch Germany 8 91 0.8× 37 0.4× 30 0.3× 75 1.2× 34 0.6× 29 258
B‐M Frost Sweden 8 86 0.7× 66 0.7× 66 0.7× 28 0.4× 26 0.5× 13 256
Jan‐Peter Glossmann Germany 10 106 0.9× 179 1.8× 64 0.7× 59 0.9× 51 0.9× 18 339

Countries citing papers authored by Pamela Egan

Since Specialization
Citations

This map shows the geographic impact of Pamela Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Egan more than expected).

Fields of papers citing papers by Pamela Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Egan. The network helps show where Pamela Egan may publish in the future.

Co-authorship network of co-authors of Pamela Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Egan. A scholar is included among the top collaborators of Pamela Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Egan. Pamela Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wulff‐Burchfield, Elizabeth, Pamela Egan, Lee A. Hugar, et al.. (2024). Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study. Journal of Geriatric Oncology. 15(5). 101774–101774. 1 indexed citations
2.
Egan, Pamela, Ari Pelcovits, S. E. Donnelly, et al.. (2023). Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407). Blood. 142(Supplement 1). 259–259.
3.
Ollila, Thomas, et al.. (2022). Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study. The Oncologist. 27(7). 532–e542. 7 indexed citations
4.
Pelcovits, Ari, et al.. (2021). Impact of Early Palliative Care on End-of-Life Outcomes in Hematologic Malignancies. Journal of Palliative Medicine. 25(4). 556–561. 8 indexed citations
5.
Pelcovits, Ari, et al.. (2021). Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia. Supportive Care in Cancer. 29(9). 5323–5327. 15 indexed citations
6.
Olszewski, Adam J., Anna Chorzalska, Thomas Ollila, et al.. (2021). Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma. Blood Advances. 5(24). 5525–5535. 24 indexed citations
7.
Sadler, Brooke, Anna Chorzalska, Dennis M. Bonal, et al.. (2021). Whole Genome Sequencing Identifies a Recurrent Mutation in Complement Factor I (CFI) in Primary Myelofibrosis (PMF). Blood. 138(Supplement 1). 1472–1472. 2 indexed citations
8.
Bélanger, Emmanuelle, et al.. (2020). Early Palliative Care Services and End-of-Life Care in Medicare Beneficiaries with Hematologic Malignancies: A Population-Based Retrospective Cohort Study. Journal of Palliative Medicine. 24(1). 63–70. 18 indexed citations
9.
Olszewski, Adam J., Anna Chorzalska, Thomas Ollila, et al.. (2020). Cerebrospinal Fluid (CSF) Analysis of Tumor-Specific Cell-Free DNA (cfDNA) As a Diagnostic and Prognostic Tool for Central Nervous System (CNS) Invasion in Lymphoma. Blood. 136(Supplement 1). 21–22. 5 indexed citations
10.
11.
Egan, Pamela, et al.. (2020). Antibiotic use during cytarabine consolidation in acute myeloid leukemia. Annals of Hematology. 100(1). 79–84. 3 indexed citations
12.
Olszewski, Adam J., Anna Chorzalska, Diana O. Treaba, et al.. (2019). Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas. Blood. 134(Supplement_1). 2800–2800. 1 indexed citations
13.
Olszewski, Adam J., et al.. (2019). Evaluating the Incidence of Cardiovascular and Thrombotic Events in Secondary Polycythemia. Blood. 134(Supplement_1). 3511–3511. 6 indexed citations
14.
Garg, Megha, et al.. (2019). Attitudes Toward Advocacy Do Not Match Actions: A Cross-sectional Survey of Residents and Fellows.. PubMed. 102(3). 34–37. 6 indexed citations
15.
Egan, Pamela & John L. Reagan. (2018). The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia. OncoTargets and Therapy. Volume 11. 8265–8272. 23 indexed citations
16.
LeBlanc, Thomas W., Pamela Egan, & Adam J. Olszewski. (2018). Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia. Blood. 132(7). 717–726. 55 indexed citations
17.
Egan, Pamela, et al.. (2009). Hospitality, human services, and tourism. Cambridge University Press eBooks. 1 indexed citations
18.
Egan, Pamela, et al.. (2009). Food, agriculture, and natural resources. Cambridge University Press eBooks.
19.
Egan, Pamela, et al.. (2008). Chemotherapy for bladder cancer: A United Kingdom practice survey. Journal of Clinical Oncology. 26(15_suppl). 16078–16078. 1 indexed citations
20.
Recht, Lawrence D., Gitte Strauss, Thomas J. FitzGerald, et al.. (1990). Preirradiation Chemotherapy of Supratentorial Malignant Primary Brain Tumors with Intracarotid cis-Platinum (CDDP) and i.v. BCNU. American Journal of Clinical Oncology. 13(2). 125–131. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rocío Cárdenas‐Cardós Breakdown of academic impact, for papers by Stacy Epstein Breakdown of academic impact, for papers by С. Р. Варфоломеева Breakdown of academic impact, for papers by Giacomo Loseto Breakdown of academic impact, for papers by Marion Strullu Breakdown of academic impact, for papers by Deepam Pushpam Breakdown of academic impact, for papers by Anita J. Kumar Breakdown of academic impact, for papers by Holger Hauch Breakdown of academic impact, for papers by B‐M Frost Breakdown of academic impact, for papers by Jan‐Peter Glossmann
Rankless by CCL
2026